These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 25843906)

  • 1. Are SK channels a logical target for treating ventricular arrhythmias? First, do no harm.
    Van Wagoner DR
    Trends Cardiovasc Med; 2015 Aug; 25(6):515-6. PubMed ID: 25843906
    [No Abstract]   [Full Text] [Related]  

  • 2. SK channels and ventricular arrhythmias in heart failure.
    Chang PC; Chen PS
    Trends Cardiovasc Med; 2015 Aug; 25(6):508-14. PubMed ID: 25743622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding role of SK channels in cardiac electrophysiology.
    Mahida S
    Heart Rhythm; 2014 Jul; 11(7):1233-8. PubMed ID: 24681007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel ion channel targets in atrial fibrillation.
    Hancox JC; James AF; Marrion NV; Zhang H; Thomas D
    Expert Opin Ther Targets; 2016 Aug; 20(8):947-58. PubMed ID: 26918581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic Effect of Either Negative Modulation or Blockade of Small Conductance Ca2+-activated K+ Channels on Ventricular Fibrillation in Guinea Pig Langendorff-perfused Heart.
    Diness JG; Kirchhoff JE; Sheykhzade M; Jespersen T; Grunnet M
    J Cardiovasc Pharmacol; 2015 Sep; 66(3):294-9. PubMed ID: 25978690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic inhibition of small-conductance calcium-activated potassium (SK) channels by NS8593 reveals atrial antiarrhythmic potential in horses.
    Haugaard MM; Hesselkilde EZ; Pehrson S; Carstensen H; Flethøj M; Præstegaard KF; Sørensen US; Diness JG; Grunnet M; Buhl R; Jespersen T
    Heart Rhythm; 2015 Apr; 12(4):825-35. PubMed ID: 25542425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of antiarrhythmic drugs on small conductance calcium - activated potassium channels.
    Simó-Vicens R; Sauter DRP; Grunnet M; Diness JG; Bentzen BH
    Eur J Pharmacol; 2017 May; 803():118-123. PubMed ID: 28322838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventricular arrhythmias in heart failure: to treat or not to treat?
    Deedwania PC
    Cardiol Clin; 1994 Feb; 12(1):115-32. PubMed ID: 8181020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic principle of SK channel inhibition in atrial fibrillation.
    Skibsbye L
    Dan Med J; 2015 Jun; 62(6):. PubMed ID: 26036893
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prognostic value of ventricular arrhythmias].
    Vergara G
    Ital Heart J Suppl; 2001 Dec; 2(12):1291-5. PubMed ID: 11838350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiac arrhythmias (VIII). The pharmacological treatment of ventricular tachycardias].
    Arenal A; Almendral J; Villacastín J; Pastor A; Martínez Alday J; Peinado R; Medina O
    Rev Esp Cardiol; 1993 Aug; 46(8):497-505. PubMed ID: 8378568
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of Apamin-Sensitive Calcium-Activated Small-Conductance Potassium Currents on the Mechanisms of Ventricular Fibrillation in Pacing-Induced Failing Rabbit Hearts.
    Yin D; Hsieh YC; Tsai WC; Wu AZ; Jiang Z; Chan YH; Xu D; Yang N; Shen C; Chen Z; Lin SF; Chen PS; Everett TH
    Circ Arrhythm Electrophysiol; 2017 Feb; 10(2):e004434. PubMed ID: 28213506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ablation of ventricular arrhythmia in patients with heart failure.
    Chik WW; Marchlinski FE
    Heart Fail Clin; 2015 Apr; 11(2):319-36. PubMed ID: 25834978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ranolazine therapy in drug-refractory ventricular arrhythmias.
    Curnis A; Salghetti F; Cerini M; Vizzardi E; Sciatti E; Vassanelli F; Villa C; Inama L; Raweh A; Giacopelli D; Bontempi L
    J Cardiovasc Med (Hagerstown); 2017 Jul; 18(7):534-538. PubMed ID: 28368882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Electrophysiologic features of the modulation of ATP-dependent potassium channels].
    Schwartz PJ; Vanoli E; Priori SG
    Cardiologia; 1995 Dec; 40(12 Suppl 1):83-6. PubMed ID: 8998786
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiarrhythmic effect of parenteral magnesium on ventricular tachycardia associated with long QT syndrome.
    Kurita T
    Magnes Res; 1994 Jun; 7(2):155-7. PubMed ID: 7999530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arrhythmogenic calmodulin mutations impede activation of small-conductance calcium-activated potassium current.
    Yu CC; Ko JS; Ai T; Tsai WC; Chen Z; Rubart M; Vatta M; Everett TH; George AL; Chen PS
    Heart Rhythm; 2016 Aug; 13(8):1716-23. PubMed ID: 27165696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of N-type Ca2+ channels ameliorates an imbalance in cardiac autonomic nerve activity and prevents lethal arrhythmias in mice with heart failure.
    Yamada Y; Kinoshita H; Kuwahara K; Nakagawa Y; Kuwabara Y; Minami T; Yamada C; Shibata J; Nakao K; Cho K; Arai Y; Yasuno S; Nishikimi T; Ueshima K; Kamakura S; Nishida M; Kiyonaka S; Mori Y; Kimura T; Kangawa K; Nakao K
    Cardiovasc Res; 2014 Oct; 104(1):183-93. PubMed ID: 25100767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Congestive heart failure and arrhythmia].
    Kasanuki H
    Nihon Rinsho; 1993 May; 51(5):1354-61. PubMed ID: 8101240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic Mechanisms of SK Channel Inhibition in the Rat Atrium.
    Skibsbye L; Wang X; Axelsen LN; Bomholtz SH; Nielsen MS; Grunnet M; Bentzen BH; Jespersen T
    J Cardiovasc Pharmacol; 2015 Aug; 66(2):165-76. PubMed ID: 25856531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.